Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
Clinical trial NCT03593590 · COMPLETED
Trial details
- NCT number
- NCT03593590
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-11-12
- Primary completion
- 2026-01-19
- Enrollment
- 1710
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.